Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in BTAIQ — BioXcel Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to BTAIQ Full portfolio

Position in BTAIQ

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,114
+$327 QoQ
Shares Held
4,337
+0.4% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 47 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BTAIQ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $472,275,691 across 58 Drug Manufacturers - Specialty & Generic names. BTAIQ ranks #49 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,809,278 $130,014,715
2 HLN
Haleon plc
 4,924,330 $45,943,997
3 NBIX
Neurocrine Biosciences Inc
 253,026 $42,644,999
4 UTHR
UNITED THERAPEUTICS Corp
 74,303 $40,259,592
5 ELAN
Elanco Animal Health Inc
 976,361 $24,028,242
6 HIMS
Hims & Hers Health, Inc.
 559,389 $19,394,014
7 VTRS
Viatris Inc
 1,175,495 $18,666,859
8 TAK
Takeda Pharmaceutical Co Ltd
 1,150,820 $18,447,643

All Filings in BTAIQ

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,114 4,337
2025-12-31 $6,919 4,325
2025-09-30 $41,768 16,316
2025-06-30 $30,623 16,919
2025-03-31 $24,954 12,293
2024-12-31 — 199,010
2024-09-30 — 185,058
2024-06-30 — 133,676
2024-03-31 — 123,086
2023-12-31 — 77,829
2023-09-30 — 74,919
2023-06-30 — 77,381
2023-03-31 — 47,611
2022-12-31 — 17,533
2022-09-30 — 18,701
2022-06-30 — 16,830
2022-03-31 — 13,745
2021-12-31 — 19,704
2021-09-30 — 9,815
2021-06-30 — 9,456
2021-03-31 — 12,580
2020-12-31 — 30,947
2020-09-30 — 12,139
2020-06-30 — 15,344
2020-03-31 — 8,198